Clinical and immune profiling for cancer of unknown primary site

ConclusionsThe survival outcome of CUP remains unsatisfactory. However, our clinical and immune profiling of CUP has revealed a potential to benefit from immunotherapy, with ICIs thus being a potential option for CUP treatment.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research